CaveoVasc System - a New Femoral Vascular Access and Closure Device

NCT02694549 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-08-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the performance and safety of the CaveoVasc® System for femoral vascular access and for prevention of bleeding from the femoral artery puncture site.

Conditions

  • Catheterization Via a Femoral Sheath ≤ 6Fr

Interventions

DEVICE

CaveoVasc

Sponsors & Collaborators

  • MedPass International

    collaborator INDUSTRY
  • CaveoMed GmbH

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-09
Primary Completion
2016-10-10
Completion
2016-11-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694549 on ClinicalTrials.gov